Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Reference

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)
include FRENDA results (AMENDA + additional results, but less precise)

Search term:

Results 1 - 10 of 21 > >>
EC Number BRENDA No. Title Journal Volume Pages Year Organism PubMed ID
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2762996 Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections Eur. J. Med. Chem. 145 235-251 2018 Staphylococcus aureus 29328999
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2762996 Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections Eur. J. Med. Chem. 145 235-251 2018 Staphylococcus aureus Newman 29328999
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2743065 Discovery of potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections J. Med. Chem. 59 3215-3230 2016 Staphylococcus aureus 26999509
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2743065 Discovery of potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections J. Med. Chem. 59 3215-3230 2016 Staphylococcus aureus Newman 26999509
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2763350 Novel terminal biphenyl-based diapophytoene desaturases (CrtN) inhibitors as anti-MRSA/VISR/LRSA agents with reduced hERG activity J. Med. Chem. 61 224-250 2018 Staphylococcus aureus 29243920
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2763350 Novel terminal biphenyl-based diapophytoene desaturases (CrtN) inhibitors as anti-MRSA/VISR/LRSA agents with reduced hERG activity J. Med. Chem. 61 224-250 2018 Staphylococcus aureus Newman 29243920
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2743333 Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence Nat. Chem. Biol. 12 174-179 2016 Staphylococcus aureus 26780405
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2743333 Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence Nat. Chem. Biol. 12 174-179 2016 Staphylococcus aureus Newman 26780405
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2715338 4,4'-diapophytoene desaturase: catalytic properties of an enzyme from the C30 carotenoid pathway of Staphylococcus aureus J. Bacteriol. 181 6184-6187 1999 Staphylococcus aureus 10498735
Show all pathways known for 1.3.8.2Display the word mapDisplay the reaction diagram Show all sequences 1.3.8.2714566 Carotenoid production in Bacillus subtilis achieved by metabolic engineering Biotechnol. Lett. 31 1789-1793 2009 Staphylococcus aureus 19618272
Results 1 - 10 of 21 > >>